Atlas Trials

BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma

Clinical trial NCT01034631 · COMPLETED

Trial details

NCT number
NCT01034631
Sponsor
Hoosier Cancer Research Network
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Renal Cell Carcinoma
Start date
2010-01-01
Primary completion
2016-12-01
Enrollment
154

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.